What's Happening?
The World Health Organization (WHO) released its Global Tuberculosis Report 2026, indicating continued progress in reducing TB cases and deaths globally. In 2025, an estimated 10.6 million people developed TB, and 1.1 million died from the disease. This
represents a 35% drop in deaths since 2015, meeting the first mortality milestone of WHO’s End TB Strategy, albeit five years later than planned. The report highlights that domestic funding for TB increased by 14% to US$ 5.6 billion between 2024 and 2025, which helped offset a similar decline in international financing. Despite these gains, the global TB incidence rate has only fallen by 14% since 2015, far short of the 50% reduction target for 2025. TB remains the leading cause of death from a single infectious agent, with the burden heavily concentrated in 30 countries. Significant disparities exist across regions, with incidence rising in the Americas for the fifth consecutive year in 2025.
Why It's Important?
The report underscores the critical role of sustained investment and strengthened health systems in combating tuberculosis. The increase in domestic funding demonstrates a commitment from some governments to protect public health gains, even as international funding faces constraints. However, the persistent gaps in diagnosis, treatment, prevention, and research funding pose a significant threat to global health security. The uneven progress across regions, particularly the rise in incidence in the Americas, indicates that certain populations remain highly vulnerable. Insufficient investment in TB research, which stood at US$ 1.2 billion in 2023 against a US$ 5 billion annual target, means that the development of new vaccines, diagnostics, and treatments is severely hampered. This lack of innovation prolongs the epidemic and continues to claim over a million lives annually from a preventable and treatable disease.
What's Next?
The WHO is calling on governments and partners to intensify their efforts to combat TB. Key actions include strengthening political commitment, ensuring sustainable financing, expanding access to prevention, rapid diagnosis, and effective treatment, and accelerating investment in new tools. The organization emphasizes the urgent need for faster progress to meet the goal of ending the TB epidemic. This will likely involve increased advocacy for greater financial contributions from both domestic and international sources, as well as strategic partnerships to bridge research and development gaps. Countries with rising incidence rates, such as those in the Americas, will need to implement targeted interventions and strengthen their health infrastructure to reverse these trends. The focus will also be on improving diagnostic coverage, as 2.2 million people were either undiagnosed or unreported in 2025, and increasing the uptake of WHO-recommended rapid diagnostic tests and treatment regimens for drug-resistant TB.
Beyond the Headlines
The WHO's report reveals a deeper narrative about global health equity and the resilience of health systems under financial pressure. The reliance on domestic funding to offset international shortfalls highlights a potential shift in responsibility for global health initiatives, which could disproportionately affect lower-income countries. The continued struggle against TB, despite it being preventable and treatable, points to systemic issues such as inadequate healthcare infrastructure, social determinants of health, and persistent inequalities in access to care. The insufficient investment in research also raises ethical questions about the global community's commitment to eradicating diseases that primarily affect vulnerable populations. Addressing TB effectively requires not just medical interventions but also broader socio-economic development, improved living conditions, and robust public health campaigns to ensure that no one is left behind in the fight against this ancient disease.
